SYRE - Spyre Therapeutics, Inc.
IEX Last Trade
24.02
0.155 0.645%
Share volume: 7,393
Last Updated: Thu 26 Dec 2024 08:30:27 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$23.86
0.16
0.65%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-03-02 | 2023-05-11 | 2023-08-11 | 2023-11-09 | 2024-02-29 | 2024-05-09 | |
| Total revenue | 625.000 K | 174.000 K | 168.000 K | 198.000 K | 688.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 625.000 K | 174.000 K | 168.000 K | 198.000 K | 688.000 K | 0.000 | 0.000 | 0.000 | |
| -72.16% | -3.45% | 17.86% | 247.47% | -100.00% | nan% | nan% | |||
| Operating expenses | 23.048 M | 18.929 M | 19.330 M | 19.004 M | 29.448 M | 33.244 M | 47.754 M | 47.774 M | |
| Selling general and admin | 7.675 M | 6.952 M | 5.079 M | 5.228 M | 12.062 M | 8.584 M | 14.072 M | 12.846 M | |
| Research and development | 15.373 M | 11.977 M | 14.251 M | 13.776 M | 17.386 M | 24.660 M | 33.682 M | 34.928 M | |
| Total expenses | 23.048 M | 18.929 M | 19.330 M | 19.004 M | 159.934 M | 32.946 M | -82.434 M | 47.774 M | |
| -17.87% | 2.12% | -1.69% | 741.58% | -79.40% | -350.21% | 157.95% | |||
| Operating income | -22.423 M | -18.755 M | -19.162 M | -18.806 M | -159.246 M | -32.946 M | 82.434 M | -47.774 M | |
| Ebit | -22.423 M | -18.755 M | -19.162 M | -18.806 M | -159.246 M | -32.946 M | 82.434 M | -47.774 M | |
| Pretax income | -22.314 M | -18.443 M | -18.758 M | -18.458 M | -217.074 M | -40.104 M | -63.180 M | -43.825 M | |
| -17.35% | 1.71% | -1.60% | 1,076.04% | -81.53% | 57.54% | -30.63% | |||
| Income tax | 9.000 K | -209.000 K | 64.000 K | -36.000 K | 7.000 K | 3.000 K | 0.000 | 32.000 K | |
| Net income basic | -22.323 M | -18.234 M | -18.822 M | -18.422 M | -217.081 M | -40.107 M | -63.180 M | -43.857 M | |
| 18.32% | -3.22% | 2.13% | -1,078.38% | 81.52% | -57.53% | 30.58% | |||
| Net income | -22.323 M | -18.234 M | -18.822 M | -18.422 M | -217.081 M | -40.107 M | -63.180 M | -43.857 M | |
| 18.32% | -3.22% | 2.13% | -1,078.38% | 81.52% | -57.53% | 30.58% |